1. A dual ApoC-II mimetic - ApoC-III antagonist peptide as a potential treatment for hypertriglyceridemia. (August 2021) Authors: Wolska, A.; Sviridov, D.; Pourmousa, M.; Pastor, R.; Pryor, M.; Wilson, S.; Lo, L.; Ghosh, S.; Davidson, M.; Devalaraja, M.; Goldberg, I.; Basu, D.; Freeman, L.; Amar, M.; Neher, S.; Wu, M.J.; Tang, J.; Drake, S.; Cougnoux, A.; Remaley, A.T. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Quantitative Measurement Of Multiple Mri-Based Structural Measures Of Knee Osteoarthritis - Analysis Of The Oa Biomarkers Consortium Fnih Study Cohort. (March 2023) Authors: Duryea, J.; Lo, L.; Sury, M.; Bahouth, S.M.; Yin, M.; Schaefer, L.F.; Collins, J.E.; Smith, S.E. Journal: Osteoarthritis and cartilage Issue: Volume 31(2023)Supplement 1 Page Start: S95 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Topically Applied Connective Tissue Growth Factor/CCN2 Improves Diabetic Preclinical Cutaneous Wound Healing: Potential Role for CTGF in Human Diabetic Foot Ulcer Healing. (18th February 2015) Authors: Henshaw, F. R.; Boughton, P.; Lo, L.; McLennan, S. V.; Twigg, S. M. Other Names: Tesfaye Solomon Academic Editor. Journal: Journal of diabetes research Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗